Yao He

Chongqing, 400014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.

Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.

Journal: Drug design, development and therapy

Published: March 05, 2026

Higher risk of gastrointestinal stenosis and obstruction in clozapine-treated individuals with schizophrenia: a pharmacovigilance study based on the FDA adverse event reporting system database.

Higher risk of gastrointestinal stenosis and obstruction in clozapine-treated individuals with schizophrenia: a pharmacovigilance study based on the FDA adverse event reporting system database.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 02, 2025

Profiling of Potential Postmarket Risk Tracking and Pharmacovigilance Data for Avacopan.

Profiling of Potential Postmarket Risk Tracking and Pharmacovigilance Data for Avacopan.

Journal: Clinical therapeutics

Published: May 10, 2025

Re: 'Carbapenem-resistant enterobacterales acquisition following piperacillin-tazobactam vs. meropenem treatment: a propensity-matched cohort study' by Dallasheh et al.

Re: 'Carbapenem-resistant enterobacterales acquisition following piperacillin-tazobactam vs. meropenem treatment: a propensity-matched cohort study' by Dallasheh et al.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: April 28, 2025

Exploring Clinical Studies and the FDA Adverse Event Reporting System (FAERS) Database for nirogacestat-related Adverse Events.

Exploring Clinical Studies and the FDA Adverse Event Reporting System (FAERS) Database for nirogacestat-related Adverse Events.

Journal: Therapeutic innovation & regulatory science

Published: April 12, 2025

The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.

The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.

Journal: Medicine

Published: May 24, 2024

Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China.

Cost-effectiveness of Sacituzumab Govitecan versus Single-agent Chemotherapy for Patients with Metastatic Triple-Negative Breast Cancer in China.

Journal: Clinical breast cancer

Published: March 12, 2024

Optimization and preparation of a compound cod liver oil film former agent: an orthogonal design.

Optimization and preparation of a compound cod liver oil film former agent: an orthogonal design.

Journal: Frontiers in pharmacology

Published: September 20, 2023

Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition.

Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition.

Journal: Frontiers in pharmacology

Published: January 25, 2022

Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy.

Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy.

Journal: Oncology letters

Published: December 26, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026